ACADIA Pharma (ACAD) - Koefisien rega marang bathi
The current P/E ratio for ACADIA Pharmaceuticals (ACAD) demonstrates a consolidation phase, where the parameter value reaches 8.80. This trend is supported by patent exclusivity, which protects yields from generics. Stability is ensured by a strong team of neurobiologists incentivized by long-term options. The cash flow is based on the sale of Parkinson's disease treatments through insurance funds and Medicare government programs.
Rincian metrik komprehensif lan analitis ACADIA Pharmaceuticals Inc (ACAD)
- rega lan prakiraan konsensus rega:
- indikator kapitalisasi pasar:
- data ekuitas miturut neraca:
- informasi babagan utang lan solvabilitas:
Koefisien Total Utang marang Modal ACADIA Pharmaceuticals|ACAD - Utang jangka dawa marang modal|Utang jangka cendhak marang modal ACADIA Corp|ACAD - Gunggung utang perusahaan|Rasio utang marang aset resik ACADIA Pharmaceuticals Inc.|ACAD - Utang jangka dawa perusahaan|Kewajiban jangka cendhak ACADIA Pharmaceuticals|Rasio jangkoan perantara acadia-pharm.com
- data bathi resik lan rasio valuasi:
ACAD - Bathi resik|Proyeksi bathi mangsa ngarep ACADIA Pharmaceuticals|ACAD - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi ACADIA Pharma|ACAD - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ACADIA Pharmaceuticals Inc.|ACAD - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) ACADIA Pharmaceuticals|ACAD - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan acadia-pharm.com|ACAD - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep ACADIA Pharmaceuticals
Analisis umum perusahaan:acadia-pharm.com - ACAD
For ACADIA Pharmaceuticals (ACAD), this ratio reflects the market value of the business relative to its net income, allowing for an assessment of the asset's premium. By analyzing the company's P/E ratio, an investor can compare current capitalization with financial resilience regarding Nuplazid patent disputes and Daybue costs, identifying either an undervalued asset or the risk of inflated expectations amid operating expenses.
Analisis perusahaan pesaing
Pangali P/E biogen.com|Pangali P/E NBIX|Koefisien rega marang bathi Regencell Bioscience Ltd RGC|Pangali P/E AXSM (Axsome Therapeutics Inc)|Pangali P/E Xenon Corp XENE|Viking Therapeutics - Pangali P/E|SUPN (supernus.com) - Pangali rega marang bathi|CPRX: Pangali P/E|DNLI - Periode bali modal bisnis|HRMY (Harmony Pharma) - Pangali P/E|Pangali P/E Biohaven Corp|Koefisien rega marang bathi AMLX (Amylyx Pharmaceuticals)|TRVI (trevitherapeutics.com) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Praxis Precision Medicines, Inc. PRAX|AVXL (Anavex) - Kapitalisasi marang bathi resik|CeriBell Corp - Pangali P/E|Nilai perusahaan marang bathi resik PRTA (Prothena Corporation)|ALEC: Pangali P/E|annexonbio.com (ANNX) - Pangali P/E|Rasio rega marang bathi Omeros Corp|NGNE: Nilai perusahaan marang bathi resik|Rasio rega marang bathi AC Immune Corp (ACIU)|Koefisien rega marang bathi Voyager Corp VYGR|Pangali P/E NMRA (Neumora Therapeutics)|Pangali P/E scilexholding.com SCLX|Tevogen Bio - Pangali P/E|Alpha Cognition (ACOG) - Koefisien rega marang bathi|CGTX: Pangali P/E|Kapitalisasi marang bathi Inhibikase Pharma (IKT)|Koefisien rega marang bathi SAVA|Pangali P/E Assertio Therapeutics|Koefisien rega marang bathi COYA (Coya Therapeutics, Inc.)|Rasio rega pasar marang bathi resik VTGN|Pangali P/E OVID (Ovid Therapeutics)|Periode bali modal bisnis Acumen Pharmaceuticals, Inc (ABOS)|CervoMed Inc. - Pangali P/E|Alterity Therapeutics (ATHE) - Koefisien rega marang bathi|CLNN: Pangali P/E|PepGen (PEPG) - Pangali P/E|Rasio rega marang bathi Jupiter Neurosciences|Rasio rega marang bathi RLMD|Rasio rega marang bathi Annovis Bio, Inc. (ANVS)|Periode bali modal bisnis gracetx.com|Pangali P/E AIFF (Firefly Neuroscience)|Pangali P/E ANEW Medical KLTO|NeuroSense Therapeutics, Ltd. - Pangali P/E|Reviva Pharmaceuticals, Inc. (RVPH) - Koefisien rega marang bathi|MTVA: Pangali P/E|neuraxis.com (NRXS) - Pangali P/E|HSDT (Helius Medical Technologies, Inc.) - Pangali P/E|Pangali rega marang bathi PASG (Passage Bio Corp)|Rasio rega marang bathi Neuphoria Therapeutics Inc. (NEUP)|Minerva - Pangali rega marang bathi|Pangali P/E ATHA (Athira Pharma, Inc.)|addextherapeutics.com (ADXN) - Kapitalisasi marang bathi|ALZN: Koefisien rega marang bathi|CYCN - Pangali P/E|protagenic.com (PTIX) - Rasio rega marang bathi|Pasithea Therapeutics Corp. - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Cortigent Inc|Kapitalisasi marang bathi avenuetx.com ATXI|Pangali P/E BCLI|Pangali P/E Cara Therapeutics Inc. (CARA)|Pangali P/E CHRO (Chromocell Therapeutics Corporation)|ELYM - Koefisien rega marang bathi|Intra-Cellular - Pangali P/E|LBPH - Pangali P/E|MRNS: Pangali P/E|Pangali rega marang bathi NKGN|NRBO (NeuroBo) - Pangali P/E|Sage Therapeutics Inc (SAGE) - Periode bali modal bisnis|Pangali P/E SNPX|Pangali P/E trevena.com (TRVN)|Vigil Neuroscience, Inc. - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik WENA|CERE - Rasio rega marang bathi
